Reimagining druggability using chemoproteomic platforms
JN Spradlin, E Zhang, DK Nomura - Accounts of Chemical …, 2021 - ACS Publications
Conspectus One of the biggest bottlenecks in modern drug discovery efforts is in tackling the
undruggable proteome. Currently, over 85% of the proteome is still considered undruggable …
undruggable proteome. Currently, over 85% of the proteome is still considered undruggable …
Reimagining Druggability Using Chemoproteomic Platforms
JN Spradlin, E Zhang… - Accounts of chemical …, 2021 - pubmed.ncbi.nlm.nih.gov
One of the biggest bottlenecks in modern drug discovery efforts is in tackling the
undruggable proteome. Currently, over 85% of the proteome is still considered undruggable …
undruggable proteome. Currently, over 85% of the proteome is still considered undruggable …
Reimagining Druggability Using Chemoproteomic Platforms.
JN Spradlin, E Zhang, DK Nomura - Accounts of Chemical Research, 2021 - europepmc.org
One of the biggest bottlenecks in modern drug discovery efforts is in tackling the
undruggable proteome. Currently, over 85% of the proteome is still considered undruggable …
undruggable proteome. Currently, over 85% of the proteome is still considered undruggable …
[引用][C] Reimagining Druggability Using Chemoproteomic Platforms
JN Spradlin, E Zhang, DK Nomura - Accounts of Chemical Research, 2021 - cir.nii.ac.jp
Reimagining Druggability Using Chemoproteomic Platforms | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
[PDF][PDF] Reimagining Druggability Using Chemoproteomic Platforms
JN Spradlin, E Zhang, DK Nomura - nomuraresearchgroup.com
P53. Nat. Chem. Biol. 2020, 16, 1189− 1198. 4 This paper describes the use of
chemoproteomic platforms to reveal that the natural product asukamycin engages in …
chemoproteomic platforms to reveal that the natural product asukamycin engages in …